Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): A randomised, placebo-controlled, phase 3 study

J. C. Yao, Nicola Fazio, S. Singh, Roberto Buzzoni, Carlo Carnaghi, Edward M. Wolin, Jiri Tomasek, Markus Raderer, Harald Lahner, M. Voi, Lida Bubuteishvili Pacaud, Nicolas Rouyrre, C. Sachs, J. W. Valle, G. Delle Fave, E. Van Cutsem, M. Tesselaar, Yasuhiro Shimada, D. Y. Oh, Jonathan R. StrosbergMatthew H. Kulke, M.E. Pavel, Salvatore Tafuto

Research output: Contribution to journalArticlepeer-review

Cite this